Log in

Relevant bibliographies by topics / Israel Aircraft Industries, ltd / Journal articles

To see the other types of publications on this topic, follow the link: Israel Aircraft Industries, ltd.

Journal articles on the topic 'Israel Aircraft Industries, ltd'

Author: Grafiati

Published: 28 July 2024

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 38 journal articles for your research on the topic 'Israel Aircraft Industries, ltd.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Mazur, Anna M., Tomasz Korniluk, and Roman Domański. "Measuring and Testing the Parameters of a Battery Pack Designed for Powering Unmanned Aircraft Systems at Various Temperatures." Transactions on Aerospace Research 2017, no. 3 (2017): 46–62. http://dx.doi.org/10.2478/tar-2017-0021.

Full text

Abstract:

Abstract This paper describes results of tests dedicated to studying – in simulated environmental conditions – operation of a battery pack designed for powering unmanned aircraft systems. In particular, the tests concerned determining the electrical parameters of battery packs, with and without radiators, during their operation in changing environmental conditions and resistance to large temperature fluctuations. Amicell, a high density lithium polymer battery manufactured by the Israeli Amit Industries ltd., was selected for testing. The test results present characteristics of the batteries t

APA, Harvard, Vancouver, ISO, and other styles

2

Yamafuji, Kazuo. "Factory Tour to ShinMaywa Industries, Ltd." International Journal of Automation Technology 3, no. 5 (2009): 620–22. http://dx.doi.org/10.20965/ijat.2009.p0620.

Full text

Abstract:

The ShinMaywa Industries, Ltd., predecessor, Kawanishi Aircraft Ltd., was famed for its high-performance World War II planes, including the Type II Flying Boat, codenamed “Emily” by the Allied Forces, and the Interceptor Siden-Kai, codenamed “George.” Following defeat, Kawanishi Aircraft Ltd. was renamed ShinMaywa Industries, Ltd., founded officially in 1949. The new company, which started out producing dump trucks, but resumed aircraft manufacture in 1960. ShinMaywa now holds a high market share among Special Purpose Trucks such as dump trucks and in aircraft business exemplified by the STOL

APA, Harvard, Vancouver, ISO, and other styles

3

Gershon, B., I. Arbel, S. Hevlin, Y. Milo, and D. Saltoun. "Industrial Superplastic Forming Research and Application for Commercial Aircraft Components at Israel Aircraft Industries." Materials Science Forum 357-359 (January 2001): 527–32. http://dx.doi.org/10.4028/www.scientific.net/msf.357-359.527.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Engel, Avner, Michael Winokur, Drora Goshen, and Izhak Geva. "7.5.4 Improving the Systems Engineering Process At Israel Aircraft Industries - A Case Study." INCOSE International Symposium 11, no. 1 (2001): 824–29. http://dx.doi.org/10.1002/j.2334-5837.2001.tb02377.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Park, Hyun Bum, Chang Duk Kong, and Kyung Sun Lee. "Investigation on Damage Tolerance of Carbon/Epoxy Laminate for Aircraft Structural Design." Key Engineering Materials 488-489 (September 2011): 460–63. http://dx.doi.org/10.4028/www.scientific.net/kem.488-489.460.

Full text

Abstract:

In Korea, the KC-100, which is a small scale piston propeller general aviation aircraft, has been developed to establish a domestic certificate infrastructure and system through the BASA(Bilateral Aviation Safety Agreement) program by KAI(Korea Aerospace Industries, Ltd.). This aircraft adopted the whole composite structure concept for an environmental friendly aircraft through low fuel consumption due to structure weight reduction. However the carbon/epoxy composite structure, which is mainly used for this aircraft, is very weak against foreign object damage. Therefore the purpose of the dama

APA, Harvard, Vancouver, ISO, and other styles

6

Poteshkina, N. G., and A. A. Troshina. "Torasemid in the treatment of cardiovascular disease: the optimal use in conditions of comorbidity." Systemic Hypertension 12, no. 4 (2015): 38–41. http://dx.doi.org/10.26442/sg29113.

Full text

Abstract:

The article reviews the current clinical data on the use of one of the modern pharmacological drugs torasemide (Diuver, Teva Pharmaceutical Industries Ltd., Israel) in the treatment of cardiovascular disease in conditions of comorbidity. Presents a comprehensive view of the problem identified and a reasoned approach to the choice of diuretic therapy with clinico-pathophysiological substantiation of the use of a loop diuretic torasemid. Conceptually formed of a number of provisions on the application of one of the modern diuretic drugs in therapeutic practice in patients with arterial hypertens

APA, Harvard, Vancouver, ISO, and other styles

7

Randman, D., J. Corteen, W. M. Rainforth, B. P. Wynne, and B. Davis. "New Recrystallisation Behaviour Seen in Magnesium Alloy Elektron 675." Materials Science Forum 715-716 (April 2012): 171–72. http://dx.doi.org/10.4028/www.scientific.net/msf.715-716.171.

Full text

Abstract:

There has recently been renewed interest in magnesium alloys from both the automotive and aerospace industries. Due to the low density (approximately 35% lower than aluminium) and high specific strength, these alloys can introduce significant weight savings, and consequently fuel savings, to both vehicles and aircraft. Elektron™ 675 is a new alloy based on the magnesium-yttrium-gadolinium ternary system, developed by Magnesium Elektron Ltd. for wrought applications. Elektron™ 675 has superior mechanical properties relative to the current commercially available wrought alloys AZ31B, WE43, and Z

APA, Harvard, Vancouver, ISO, and other styles

8

Okada, Hideki, Takumi Wada, Hiroki Oribe, et al. "Intelligence Press Brake for Aircraft Skin Bending." Key Engineering Materials 968 (December 6, 2023): 117–22. http://dx.doi.org/10.4028/p-7uqwd5.

Full text

Abstract:

LVD Company NV and Kawasaki Heavy Industries, ltd. developed the cutting-edge, high performance CNC press brake [1] for high accuracy/precision bending of approx.10m (L) by 2.5m (W) size aircraft skins. Those skin sheets have complex shapes which include mainly machine milled thickness reduction area called pockets, thickness tapers, cutouts for the windows and doors. Due to those characters, the materials have large thickness variation between less than 2 mm and more than 11 mm in a single skin sheet. Here in this paper, the overview of this intelligence press brake equipment and its forming

APA, Harvard, Vancouver, ISO, and other styles

9

Gershon, B., and I. Eldror. "Research and Application of Superplastic Forming Titanium Alloys for Commercial Aircraft Parts." Materials Science Forum 475-479 (January 2005): 3047–50. http://dx.doi.org/10.4028/www.scientific.net/msf.475-479.3047.

Full text

Abstract:

Titanium alloys sheets have many attractions for the aerospace industry owing to their high strength, low density, heat resistance and other useful properties. Many of the sheet metal structures in airframes have complex shapes and compound curvatures with intricate details. Superplastic forming (SPF), a most recent advancement in titanium sheet forming technology, exploits the excellent characteristic of >1000% elongation potential for the fabrication of complex configurations not achievable by conventional methods. SPF technology can also reduce manufacturing cost by shortening the prepar

APA, Harvard, Vancouver, ISO, and other styles

10

Yevtodyeva, M. "Military-Technical Cooperation of India with USA, Israel and EU Countries in the Context of “Make in India” Program." World Economy and International Relations 68, no. 12 (2024): 26–37. https://doi.org/10.20542/0131-2227-2024-68-12-26-37.

Full text

Abstract:

The article analyzes the key trends in India’s military-technical cooperation with Western countries and Israel in the last decade, including the increased diversification of defense procurement due to the growing number of contracts with these countries and the shift in emphasis of the Indian acquisition strategy from obtaining of weapon platforms to the procurement of components and development of the national defense industry. The primary focus of the paper are the key features of India’s military-technical cooperation with the USA, Israel and France as the main (besides Russia) suppliers o

APA, Harvard, Vancouver, ISO, and other styles

11

Jiang, Junxia, Shenglin Zhang, and Yuxiao He. "Wheel design and motion analysis of a new heavy-duty AGV in aircraft assembly lines." Assembly Automation 40, no. 3 (2019): 387–97. http://dx.doi.org/10.1108/aa-01-2019-0009.

Full text

Abstract:

Purpose The flexible automatic transportation and manual assembly jobs for large aircraft components demand an automated guided vehicle (AGV) system with heavy-duty capacity and omnidirectional movability. This paper aims to propose a four driving-steering wheels-four supporting-steering wheels (4DSW-4SSW) layout plan to enhance the controllability and moving stability of AGV. Design/methodology/approach The anti-vibration structure of DS wheels and high-torque steering mechanism of SS wheels with tapered rolling bearings are rigorously designed to meet the functional requirements. Based on th

APA, Harvard, Vancouver, ISO, and other styles

12

Pransky, Joanne. "The Pransky interview: Professor Moshe Shoham, Founder of Mazor Robotics and Microbot Medical." Industrial Robot: An International Journal 41, no. 5 (2014): 393–97. http://dx.doi.org/10.1108/ir-07-2014-0367.

Full text

Abstract:

Purpose – The purpose of this article is to present a “Q&A interview” conducted by Joanne Pransky of the Industrial Robot Journal as a method to impart the combined technological, business and personal experience of a prominent, robotic industry engineer-turned entrepreneur regarding the evolution, commercialization and challenges of bringing a technological invention to market. Design/methodology/approach – The interviewee is Professor Moshe Shoham, Director of the Robotics Laboratory, Department of Mechanical Engineering, Technion, Israel Institute of Technology. Professor Shoham is also

APA, Harvard, Vancouver, ISO, and other styles

13

Gentle, Matthew, Neal Finch, James Speed, and Anthony Pople. "A comparison of unmanned aerial vehicles (drones) and manned helicopters for monitoring macropod populations." Wildlife Research 45, no. 7 (2018): 586. http://dx.doi.org/10.1071/wr18034.

Full text

Abstract:

Context Developments in the use of remote aircraft, or unmanned aerial systems (UAS), for ecological study have been rapid. Helicopter surveys have proven to be a reliable, repeatable method for broad-scale monitoring of harvested kangaroo populations in Australia’s rangelands, but the recent availability of long-range UAS may offer improvements in detectability and cost efficiency. Aims We aimed to test the ability of a long-range UAS (Spylite, Bluebird Aero Systems Ltd, Kadima, Israel) to survey macropod populations at a landscape scale, and validate the results against those from the curren

APA, Harvard, Vancouver, ISO, and other styles

14

Orlova, O. L., A. P. Polozkova, N. A. Oborotova, et al. "CREATING LABORATORY TECHNOLOGY OF GENERIC EPIRUBICIN PHARMECEUTICAL DOSAGE FORM." Russian Journal of Biotherapy 15, no. 4 (2016): 72–77. http://dx.doi.org/10.17650/1726-9784-2016-15-4-72-77.

Full text

Abstract:

Introduction. Governments around the world seek to reduce rapidly rising health care costs. Using the same high quality and often cheaper than the original brands, generics greatly reduces costs while providing an adequate quality of care. Therefore the development of generic medicines is an important task. The purpose of the study - the reproduction of the pharmaceutical dosage form for creation of national drug-generic epirubicin. Materials and methods. The study used a substance epirubicin (Ph. Eur current edition, Teva Pharmaceutical Industries Ltd., Israel); “Farmorubicin”, production “Pf

APA, Harvard, Vancouver, ISO, and other styles

15

Sajatovic, Martha, Amanda Wilhelm, Stacy Finkbeiner, et al. "Long-Term Safety and Efficacy of Deutetrabenazine in Younger and Older Patients With Tardive Dyskinesia." CNS Spectrums 26, no. 2 (2021): 157–58. http://dx.doi.org/10.1017/s1092852920002527.

Full text

Abstract:

AbstractBackgroundTardive dyskinesia (TD) is an involuntary movement disorder that is more prevalent in older patients. However, there is limited information on TD treatment for this population. In two 12-week pivotal trials (ARM-TD and AIM-TD), TD patients demonstrated significant improvements in Abnormal Involuntary Movement Scale (AIMS) score with deutetrabenazine versus placebo.MethodsPatients who completed ARM-TD or AIM-TD enrolled in an open-label extension (OLE) study. This post hoc analysis assessed change and percent change from baseline in AIMS score, response rates for ≥50% AIMS imp

APA, Harvard, Vancouver, ISO, and other styles

16

Hauser, Robert A., Hadas Barkay, Hubert H. Fernandez, et al. "Long-Term Deutetrabenazine Treatment Is Associated With Continued Improvement in Tardive Dyskinesia in the Completed 3-Year Open-Label Extension Study." CNS Spectrums 26, no. 2 (2021): 162. http://dx.doi.org/10.1017/s1092852920002606.

Full text

Abstract:

AbstractBackgroundThe 12-week ARM-TD and AIM-TD studies in tardive dyskinesia (TD) patients showed statistically significant improvements in TD symptoms with deutetrabenazine. The completed open-label extension (OLE) study (SD-809-C−20) evaluated long-term efficacy and safety of deutetrabenazine in TD.MethodsPatients who completed ARM-TD or AIM-TD enrolled in the OLE study, with deutetrabenazine dose titrated based on dyskinesia control and tolerability. Change from baseline in Abnormal Involuntary Movement Scale (AIMS) score was assessed by local site raters. Treatment success was evaluated l

APA, Harvard, Vancouver, ISO, and other styles

17

Chaijale, Nayla, Joseph Bona, Hadas Barkay, Amanda Wilhelm, and Mark Forrest Gordon. "Deutetrabenazine Reduces Severe Tardive Dyskinesia Movements in a 3-year Open-Label Extension Trial." CNS Spectrums 26, no. 2 (2021): 156. http://dx.doi.org/10.1017/s1092852920002497.

Full text

Abstract:

AbstractBackgroundThere are no established treatment guidelines for tardive dyskinesia (TD) based on movement severity. The 12-week ARM-TD and AIM-TD studies in TD patients with baseline Abnormal Involuntary Movement Scale (AIMS) total score (items 1–7) ≥6 showed clinically significant improvements in AIMS score with deutetrabenazine versus placebo. Patients who completed these studies were eligible for the open-label extension (OLE) trial. This post-hoc analysis evaluated deutetrabenazine in TD patients with severe movements.MethodsSubgroups were defined by upper quartile of baseline total AI

APA, Harvard, Vancouver, ISO, and other styles

18

Hauser, Robert A., Hadas Barkay, Hubert H. Fernandez, et al. "Long-Term Efficacy and Safety of Deutetrabenazine in Patients with Tardive Dyskinesia by Concomitant Dopamine-Receptor Antagonist Use." CNS Spectrums 27, no. 2 (2022): 246. http://dx.doi.org/10.1017/s1092852922000566.

Full text

Abstract:

AbstractIntroductionTardive dyskinesia (TD) is an involuntary movement disorder that can result from exposure to dopamine-receptor antagonists (DRAs). Deutetrabenazine demonstrated significant improvements in Abnormal Involuntary Movement Scale (AIMS) scores in the 12-week pivotal trials (ARM-TD/AIM-TD). This post hoc analysis assessed the long-term efficacy and safety of deutetrabenazine by baseline DRA use.MethodsPatients who completed ARM-TD or AIM-TD enrolled in the 3-year, open-label extension (OLE) study, with deutetrabenazine dose titrated based on dyskinesia control and tolerability. C

APA, Harvard, Vancouver, ISO, and other styles

19

Wilhelm, Amanda, Karen E. Anderson, Hubert H. Fernandez, et al. "Comparison of Safety and Tolerability of Deutetrabenazine During Titration and Maintenance in Patients with Tardive Dyskinesia." CNS Spectrums 26, no. 2 (2021): 164. http://dx.doi.org/10.1017/s1092852920002643.

Full text

Abstract:

AbstractBackgroundDeutetrabenazine is approved to treat tardive dyskinesia (TD) in adults and is titrated weekly by 6 mg/day, from 12 to 48 mg/day, based on dyskinesia control and tolerability. This analysis compared the safety of deutetrabenazine during titration versus maintenance.MethodsSafety was assessed during titration versus maintenance using integrated data from two 12-week placebo-controlled studies (ARM-TD and AIM-TD) and the open-label extension study. Rates were compared for overall and serious adverse events (AEs), AEs leading to discontinuation, treatment-related AEs, common AEs

APA, Harvard, Vancouver, ISO, and other styles

20

Barkay, Hadas, Robert A. Hauser, Amanda Wilhelm, Maria Wieman, Mark Forrest Gordon, and Juha-Matti Savola. "Minimal Clinically Important Difference in AIMS Score Based on CGIC and PGIC in Patients With Tardive Dyskinesia Treated With Deutetrabenazine." CNS Spectrums 26, no. 2 (2021): 159. http://dx.doi.org/10.1017/s1092852920002552.

Full text

Abstract:

AbstractBackgroundDeutetrabenazine is FDA approved for tardive dyskinesia (TD) based on two 12-week, placebo-controlled studies evaluating safety and efficacy in patients with baseline Abnormal Involuntary Movement Scale (AIMS) score ≥6. Deutetrabenazine reduced overall AIMS scores compared with placebo in ARM-TD (–3.0 vs –1.6, P=0.019) and AIM-TD (24 mg/day, –3.2 vs –1.4, P=0.003; 36 mg/day, –3.3 vs –1.4, P=0.001). This analysis assessed Minimal Clinically Important Difference (MCID) in AIMS score in patients with TD treated with deutetrabenazine.MethodsMCID is the smallest change from baseli

APA, Harvard, Vancouver, ISO, and other styles

21

Hauser, Robert A., Hadas Barkay, Hubert H. Fernandez, et al. "Effects of Long-Term Deutetrabenazine Treatment in Patients with Tardive Dyskinesia and Underlying Psychiatric or Mood Disorders." CNS Spectrums 27, no. 2 (2022): 245–46. http://dx.doi.org/10.1017/s1092852922000554.

Full text

Abstract:

AbstractIntroductionDeutetrabenazine is FDA-approved for the treatment of tardive dyskinesia (TD) in adults. In two 12-week pivotal trials (ARM-TD/AIM-TD), deutetrabenazine significantly improved Abnormal Involuntary Movement Scale (AIMS) scores and was well-tolerated. This post hoc analysis examined the efficacy and safety of long-term deutetrabenazine treatment in TD patients with comorbid psychiatric illness, including schizophrenia/schizoaffective disorder and mood disorders (bipolar/depression/other).MethodsPatients who completed ARM-TD or AIM-TD enrolled in the 3-year, open-label extensi

APA, Harvard, Vancouver, ISO, and other styles

22

Frank, Samuel, Christina Vaughan, David Stamler, et al. "Evaluation of the Safety of Deutetrabenazine at Higher Doses to Treat Chorea in Huntington’s Disease." CNS Spectrums 26, no. 2 (2021): 162–63. http://dx.doi.org/10.1017/s1092852920002618.

Full text

Abstract:

AbstractBackgroundIn the First-HD pivotal trial, the maximum deutetrabenazine dose evaluated to treat chorea associated with Huntington’s disease (HD chorea) was 48 mg/d, which is the approved maximum dose for this population. In ARC-HD, an open-label extension study evaluating the long-term efficacy and safety of deutetrabenazine to treat HD chorea, dosage ranged from 6 mg/d to 72 mg/d, with doses ≥12 mg/d administered twice daily. Doses in ARC-HD were increased by 6 mg/d per week in a response-driven manner based on efficacy and tolerability until 48 mg/d (Week 8). At the investigator’s disc

APA, Harvard, Vancouver, ISO, and other styles

23

Jimenez-Shahed, Joohi, Hadas Barkay, Karen E. Anderson, et al. "Effect of Deutetrabenazine on Metabolic Parameters in the Treatment of Tardive Dyskinesia." CNS Spectrums 26, no. 2 (2021): 159–60. http://dx.doi.org/10.1017/s1092852920002564.

Full text

Abstract:

AbstractBackgroundDeutetrabenazine, a novel vesicular monoamine transporter 2 (VMAT2) inhibitor, is approved by the FDA for treatment of tardive dyskinesia (TD) in adults. Dopamine-receptor antagonists (DRAs) are associated with worsening of metabolic parameters, including weight gain, hyperlipidemia, and elevated blood glucose. This post hoc analysis assessed the short- and long-term effects of deutetrabenazine treatment on weight and metabolic parameters in individuals treated for TD.MethodsTwo 12-week, randomized placebo-controlled trials (RCTs) of deutetrabenazine for patients with TD eval

APA, Harvard, Vancouver, ISO, and other styles

24

Khabirov, F. A., T. I. Khaibullin, E. V. Granatov, N. N. Babicheva, L. A. Aver’yanova, and S. R. Shakirzyanova. "RESULTS OF AN OPEN-LABEL COMPARATIVE RANDOMIZED CLINICAL TRIAL OF AXOGLATIRAN® FS (F-SINTEZ, RUSSIA) EFFICIENCY AND SAFETY IN COMPARISON WITH COPAXONE®-TEVA (TEVA PHARMACEUTICAL INDUSTRIES LTD., ISRAEL) IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS." Neuromuscular Diseases 6, no. 4 (2016): 28–36. http://dx.doi.org/10.17650/2222-8721-2016-6-4-28-36.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Frank, Samuel, Claudia M. Testa, David Stamler, et al. "Long-Term Efficacy and Safety of Deutetrabenazine for Chorea in Huntington’s Disease: Results From the ARC-HD Open-label Study." CNS Spectrums 26, no. 2 (2021): 164–65. http://dx.doi.org/10.1017/s1092852920002655.

Full text

Abstract:

AbstractBackgroundChorea is a prominent motor dysfunction in Huntington’s disease (HD). Deutetrabenazine, a vesicular monoamine transporter 2 (VMAT2) inhibitor, is FDA-approved for the treatment of chorea in HD. In the pivotal, 12-week First-HD trial, deutetrabenazine treatment reduced the Unified Huntington’s Disease Rating Scale (UHDRS) total maximal chorea (TMC) score versus placebo. ARC-HD, an open-label extension study, evaluated long-term safety and efficacy of deutetrabenazine dosed in a response-driven manner for treatment of HD chorea.MethodsPatients who completed First-HD (Rollover)

APA, Harvard, Vancouver, ISO, and other styles

26

Tandon, Poonam. "Preface." Pure and Applied Chemistry 81, no. 3 (2009): iv. http://dx.doi.org/10.1351/pac20098103iv.

Full text

Abstract:

The POLYCHAR 16: World Forum on Advanced Materials, organized by the University of Lucknow, was held from 17 to 21 February 2008 in the capital of the state of Uttar Pradesh, India. The annual POLYCHAR conferences have been sponsored by IUPAC for several years and are known for combining the broad field of materials sciences with a clear focus on polymeric materials (the name "POLYCHAR" is derived from the term "polymer characterization"). POLYCHAR 16 was supported by many scientific associations and industries such as IUPAC, Abdus Salam International Center for Theoretical Physics (ICTP) (Tri

APA, Harvard, Vancouver, ISO, and other styles

27

Брух, М. І., О. Р. Левицька, І. Я. Городецька, О. М. Корнієнко, and Б. П. Громовик. "Immunomodulators as objects of the pharmaceutical market. Message I. Analysis of the nomenclature of immunostimulators." Farmatsevtychnyi zhurnal, no. 4 (August 24, 2023): 3–13. http://dx.doi.org/10.32352/0367-3057.4.23.01.

Full text

Abstract:

Increasing incidence of chronic diseases (bronchial asthma, allergic conditions, cancer, multiple sclerosis), unmet clinical needs for the treatment of immune disorders such as rheumatoid arthritis, increasing number of post-covid diseases are driving the growth of the immunomodulator market. The global CAGR of the immunomodulator market is expected to be 5.4% during 2022–2027. That is why immunomodulators (immunostimulators and immunosuppressants) are a promising segment of the pharmaceutical market. The aim of the work was to study the range of immunomodulators (in terms of immunostimu

APA, Harvard, Vancouver, ISO, and other styles

28

Barkay, Hadas, Stacy Finkbeiner, Amanda Wilhelm, Jessica Alexander, Nayla Chaijale, and Mark Forrest Gordon. "Dose Patterns for Long-Term Deutetrabenazine Treatment in Patients With Tardive Dyskinesia by Baseline AIMS Item 8 Score." CNS Spectrums 27, no. 2 (2022): 239–40. http://dx.doi.org/10.1017/s1092852922000426.

Full text

Abstract:

AbstractIntroductionThe mechanism of tardive dyskinesia (TD) is complex and not well understood. Dopamine-receptor blockade in the nigrostriatal pathway may lead to a hyperdopaminergic state that can interfere with mechanisms of movement control, leading to TD. Medications for the treatment of movement disorders, including TD, typically require fine-tuning of doses to optimize control of abnormal movements; however, doses are often not titrated sufficiently. The vesicular monoamine transporter 2 inhibitor deutetrabenazine is an FDA-approved treatment for TD in adults. This post hoc analysis ex

APA, Harvard, Vancouver, ISO, and other styles

29

Kehoe, Patrick G., Nicholas Turner, Beth Howden, et al. "Losartan to slow the progression of mild-to-moderate Alzheimer’s disease through angiotensin targeting: the RADAR RCT." Efficacy and Mechanism Evaluation 8, no. 19 (2021): 1–72. http://dx.doi.org/10.3310/eme08190.

Full text

Abstract:

Background Medications that modify the renin–angiotensin system may reduce Alzheimer’s disease pathology and reduce the rate of disease progression. Objective This study investigated whether taking the antihypertensive drug losartan, in addition to normal care, would slow the progression of Alzheimer’s disease when compared with a placebo. Design A double-blind multicentre randomised controlled trial, after a 4-week open-label phase, with follow-up at 14 days and at 3, 6, 9 and 12 months. The primary outcome was based on measured imaging differences in brain volume between baseline and 12 mont

APA, Harvard, Vancouver, ISO, and other styles

30

JPT staff, _. "E&P Notes (April 2022)." Journal of Petroleum Technology 74, no. 04 (2022): 19–25. http://dx.doi.org/10.2118/0422-0019-jpt.

Full text

Abstract:

Eni Starts Area 1 Production off Mexico via MODEC FPSO MODEC said first oil has flowed through FPSO MIAMTE MV34 operating in the Offshore Area 1 block in the Bay of Campeche off Mexico. The contractor was appointed by Eni Mexico for the supply, charter, and operation of the FPSO in the Eni-operated Offshore Area 1 block in 2018. The charter contract will run for an initial 15 years, with options for extension every year thereafter up to 5 additional years. Moored in a water depth of approximately 32 m some 10 km off Mexico’s coast, the FPSO is capable of handling 90,000 B/D of oil, 75 MMcf/D o

APA, Harvard, Vancouver, ISO, and other styles

31

"Applications of NDT methods in the aircraft industry R. Bivas Israel Aircraft Industries, Ben Gurion Airport, Israel." NDT & E International 21, no. 6 (1988): 458. http://dx.doi.org/10.1016/0963-8695(88)90191-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

"Medis, Israel Aircraft Industries to develop UAV fuel cells." Fuel Cells Bulletin 2006, no. 12 (2006): 6. http://dx.doi.org/10.1016/s1464-2859(06)71266-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

"Recycled plastics surface protector seals infrastructure tunnel." Sealing Technology 2022, no. 1 (2022). http://dx.doi.org/10.12968/s1350-4789(22)70010-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Sonntag, Flavia, and Nir-Shimshon Paran. "Mishor Yamin, Survey." Hadashot Arkheologiyot - Excavations and Surveys in Israel, March 22, 2009. https://doi.org/10.69704/jhaesi.116.2004.1070.

Full text

Abstract:

During February-March 2007, an archaeological survey was conducted in the southern part of Mishor Yamin, extending south of the nuclear reactor in Dimona (Permit No. A-5063; map ref. NIG 20860/54280; OIG 15860/04280), prior to the construction of a solar-power station. The survey, undertaken on behalf of the Israel Antiquities Authority and funded by the Rotem Industries Company, Ltd., was directed by F. Sonntag and N.S. Paran, with the assistance of S. Gal (GPS).

APA, Harvard, Vancouver, ISO, and other styles

35

Sion, Ofer. "Ramla (East)." Hadashot Arkheologiyot - Excavations and Surveys in Israel, September 5, 2010. https://doi.org/10.69704/jhaesi.116.2004.1483.

Full text

Abstract:

During late April and early May 2008, a salvage excavation was conducted in the eastern part of Ramla (Permit No. A-5426; map ref. 18846/64890), prior to construction. The excavation undertaken on behalf of the Israel Antiquities Authority and underwritten by the M. Aviv Building Industries Company Ltd., was directed by O. Sion, with the assistance of A. Hajian (surveying and drafting), A. Peretz (field photography), E. Belashov (final plans), A. Ganor (pottery restoration), C. Hersch (pottery drawing), N. Amitai-Preiss (weight) and L. Kupershmidt (metallurgical laboratory).

APA, Harvard, Vancouver, ISO, and other styles

36

Toueg, Ron, Yael Gorin-Rosen, Nitzan Amitai-Preiss, and Moshe Sade. "Ramla, Shunit Street." Hadashot Arkheologiyot - Excavations and Surveys in Israel, August 11, 2016. https://doi.org/10.69704/jhaesi.116.2004.25044.

Full text

Abstract:

In October 2012, a salvage excavation was conducted adjacent to Shunit Street in Ramla (Permit No. A-6617; map ref. 188332-75/649135-206; Fig. 1), prior to the construction of two apartment complexes. The excavation, undertaken on behalf of the Israel Antiquities Authority and financed by the Mordechai Aviv Building Industries Company, Ltd., was directed by R. Toueg, with the assistance of L. Golan (area supervision), Y. Amrani and E. Bachar (administration), R. Mishayev and M. Kahan (surveying and drafting), A. Dagot and C. Ben-Ari (GPS), A. Peretz (field photography), R. Assis (trial trenche

APA, Harvard, Vancouver, ISO, and other styles

37

Yaniv, Aaron, Moshe Zilberman, and Arie Pratzovnik. "Conceptual Definition of A New Very-Light-Jet Aircraft Configuration." Journal of Aerospace Sciences and Technologies, August 10, 2023, 148–65. http://dx.doi.org/10.61653/joast.v57i1.2005.705.

Full text

Abstract:

Israel Aircraft Industries (IAI) is a world leader in the design and manufacturing of business aircraft. IAI has developed and introduced to the market several biz-jets (Westwind I and II, Astra-AKA Gulfstream G-100, and Galaxy- AKA Gulfstream G-200). All these aircraft have been in the midsize and recently "super-midsize" category. During the last two years, IAI has been evaluating a new aircraft design, the ProJet that belongs to the new, emerging category of "very-light jets" (VLJ). This lightweight twin turbofan aircraft is characterized by its small size and low target price, compared to

APA, Harvard, Vancouver, ISO, and other styles

38

-, Shruti Nadkarni, Anusha Chadha -, Vidya Agarwal -, Manan Chheda -, and Rujuta Prabhu -. "Assessing the Implications of the Red Sea Conflict on the Indian Supply Chain: A Comprehensive Analysis." International Journal For Multidisciplinary Research 6, no. 3 (2024). http://dx.doi.org/10.36948/ijfmr.2024.v06i03.17533.

Full text

Abstract:

The Red Sea, a vital trading route for India, is disrupted by the ongoing conflict between the Houthi rebels and Israel. This study aims to investigate how the dispute affects India’s supply chain in several different industries. The possible repercussions include restricted access to raw materials, delays and higher prices in maritime transportation, and concerns of energy scrutiny from disruptions in gas and oil. To lessen the impact on the economy we examine alternate trade routes and assess the potential effects on investors’ confidence. This study aims to examine and assess the diverse re

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!